NYSE: XPERXperi Inc Stock
$7.66+0.10 (+1.32%)
Updated Jul 18, 2025
XPER Price
$7.66
Fair Value Price
N/A
Market Cap
$349.96M
52 Week Low
$6.29
52 Week High
$11.08
P/E
-17.81x
P/B
0.84x
P/S
0.71x
PEG
N/A
Dividend Yield
1.31%
Revenue
$488.88M
Earnings
-$19.25M
Gross Margin
76.8%
Operating Margin
-0.94%
Profit Margin
-3.9%
Debt to Equity
0.51
Operating Cash Flow
-$28M
Beta
1.24
Next Earnings
Aug 12, 2025
Ex-Dividend
N/A
Next Dividend
N/A
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine XPER's potential to beat the market
BBuy
- Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Be the first to know about important XPER news, forecast changes, insider trades & much more!
XPER News
Overview
Due Diligence Score
–
Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how XPER scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
XPER is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
XPER is good value based on its book value relative to its share price (0.84x), compared to the US Software - Application industry average (7.16x)
P/B vs Industry Valuation
XPER is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 35 more XPER due diligence checks available for Premium users.
Valuation
XPER price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-17.81x
Industry
47.68x
Market
31.42x
XPER price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.84x
Industry
7.16x
XPER is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
XPER's financial health
Profit margin
Revenue
$114.0M
Net Income
-$18.4M
Profit Margin
-16.1%
XPER's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
XPER's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$633.5M
Liabilities
$214.6M
Debt to equity
0.51
XPER's short-term assets ($266.69M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
XPER's short-term assets ($266.69M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
XPER's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$22.3M
Investing
-$4.2M
Financing
-$16.1M
XPER's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
XPER vs App Stocks
Xperi Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.